Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-OXO-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disorders

US Patent 9724338 · Granted Aug 8, 2017

Estimated economic value: $743,000

Assignee

Inventors

View full patent text on Google Patents →